Stock Events

Stock Events

InnoCan Pharma 

$1.2900
89
-$0.01-0.77%Monday 13:48

Statistics

Day High
1.29
Day Low
1.29
52W High
12.65
52W Low
1.25
Volume
100
Avg. Volume
22
Mkt Cap
5.8B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

Sep 30Expected
Q4 2020
Q1 2021
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
-0.02
-0.02
-0.01
0
Expected EPS
N/A
Actual EPS
-0.0007

Financials

-4.22%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
26.61MRevenue
-1.12MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow INNPF. It's not an investment recommendation.
Apple
3
AAPL
Amazon
3
AMZN
NVIDIA
3
NVDA
Alphabet
3
GOOGL

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Cronos Group
CRON
Mkt Cap1.32B
Cronos Group is involved in the production and sale of cannabis and cannabis-derived products, competing in the same market as InnoCan.
Tilray Brands
TLRY
Mkt Cap431.54M
Tilray is a global leader in cannabis research, cultivation, processing, and distribution, making it a direct competitor to InnoCan Pharma.
Canopy Growth
CGC
Mkt Cap275.61M
Canopy Growth Corporation is a cannabis and cannabinoid-derived product company, competing in the same space as InnoCan Pharma.
Aurora Cannabis
ACB
Mkt Cap344.5M
Aurora Cannabis is engaged in the production, distribution, and sale of cannabis products, directly competing with InnoCan's offerings.
Direxion Daily CSI China Internet Index Bull 2X
CWEB
Mkt Cap0
Charlotte's Web Holdings, Inc. specializes in hemp-derived CBD products, competing in the cannabinoid-based product market alongside InnoCan Pharma.

About

InnoCan Pharma Corporation is a pharmaceutical enterprise dedicated to innovating drug delivery systems that integrate cannabidiol (CBD) with other pharmaceutical compounds. Its operations and development efforts span across the United States, Poland, France, and various international markets. The company actively pursues research and development into treatments for conditions such as COVID-19, leveraging CBD delivered via exosomes and liposomes. InnoCan's product line features a range of CBD-infused topical items, including eye serum, face oil, face cream, facial serum, sleeping mask, recovery lotion, and the Relief & Go spray. Beyond R&D, the corporation is also involved in the marketing and distribution of its proprietary CBD-enhanced pharmaceutical and cosmetic offerings. Established in 2018, InnoCan Pharma Corporation maintains its principal office in Calgary, Canada.
Show More
CEO
Iris Bincovich
Employees
11
Country
Canada
ISIN
CA45783P5085
WKN
000A41FTP

Listings

MU
DE
IP4.MU
STU
DE
IP40.STU
F
DE
IP40.F
STU
DE
IP4.STU

0 Comments

Share your thoughts

FAQs

What is InnoCan Pharma stock price today?▼
The current price of INNPF is $1.29 USD — it has decreased by -0.77% in the past 24 hours. Watch InnoCan Pharma stock price performance more closely on the chart.
What is InnoCan Pharma stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange InnoCan Pharma stocks are traded under the ticker INNPF.
Is InnoCan Pharma stock price growing?▼
INNPF stock has risen by +0% compared to the previous week, the month change is a -7.86% fall, over the last year InnoCan Pharma has showed a -89.8% decrease.
What is InnoCan Pharma market cap?▼
Today InnoCan Pharma has the market capitalization of 5.8B
What were InnoCan Pharma earnings last quarter?▼
INNPF earnings for the last quarter are -0 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is InnoCan Pharma revenue for the last year?▼
InnoCan Pharma revenue for the last year amounts to 26.61M USD.
What is InnoCan Pharma net income for the last year?▼
INNPF net income for the last year is -1.12M USD.
How many employees does InnoCan Pharma have?▼
As of November 9, 2026, the company has 11 employees.
In which sector is InnoCan Pharma located?▼
InnoCan Pharma operates in the Health & Wellness sector.
When did InnoCan Pharma complete a stock split?▼
The last stock split for InnoCan Pharma was on September 5, 2025 with a ratio of 1:65.
Where is InnoCan Pharma headquartered?▼
InnoCan Pharma is headquartered in Calgary, Canada.